Stocks and Investing Stocks and Investing
Fri, August 5, 2022
Thu, August 4, 2022

Joseph Schwartz Maintained (BMRN) at Buy with Increased Target to $122 on, Aug 4th, 2022


Published on 2024-10-27 22:27:38 - WOPRAI, Joseph Schwartz
  Print publication without navigation


Joseph Schwartz of SVB Leerink, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $115 to $122 on, Aug 4th, 2022.

Joseph has made no other calls on BMRN in the last 4 months.



There are 3 other peers that have a rating on BMRN. Out of the 3 peers that are also analyzing BMRN, 1 agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Andreas Argyrides of "Wedbush" Initiated at Hold and Held Target at $70 on, Monday, June 13th, 2022


These are the ratings of the 2 analyists that currently disagree with Joseph


  • Olivia Brayer of "Cantor Fitzgerald" Initiated at Buy and Held Target at $110 on, Wednesday, July 13th, 2022
  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $106 on, Monday, June 6th, 2022

Contributing Sources